← FDA Drug Approvals (Drugs@FDA)
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE
NDA · New Drug Application · Sponsor: MATRIX LABS LTD · Approved 2011-09-08
Drug application
- FDA Application #
NDA202171- Application type
- New Drug Application
- Brand name
- LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE
- Generic name
- Lamivudine
- Active ingredients
- LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- MATRIX LABS LTD
- First approval
- 2011-09-08
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown